Industry Supported Session:
Rethinking r-FSH: Real-world evidence meets AI-powered embryology
Supported by Gedeon Richter

Gedeon-Richter

Friday, November 13, 2026
12.35-13.35
Hall B

Chairperson Michael Grynberg, France
12:33-13:05 FSH biosimilars: Real-world data and clinical experience in perspective
Andreas Abraham Zadeh, Spain
13:05-13:35 Beyond the origin: AI-based evaluation of oocyte and embryo quality with biosimilar vs originator r-FSH
Marcos Meseguer, Spain

 

Skip to content